Page last updated: 2024-11-04

succinylcholine and Depressive Disorder, Treatment-Resistant

succinylcholine has been researched along with Depressive Disorder, Treatment-Resistant in 2 studies

Succinylcholine: A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for.
succinylcholine : A quaternary ammonium ion that is the bis-choline ester of succinic acid.

Depressive Disorder, Treatment-Resistant: Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)

Research Excerpts

ExcerptRelevanceReference
"This is a case of a 32-year-old male-to-female transgender patient with prolonged apnea following ECT treatment for severe, refractory depression."3.85Electroconvulsive Therapy Considerations for Transgendered Patients. ( Adams, DC; Balla, A; Grondin, LS; O'Donnell, SE; Tran, BK; Tsai, MH, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Luccarelli, J1
Fernandez-Robles, C1
Berg, SM1
Henry, ME1
Tran, BK1
O'Donnell, SE1
Balla, A1
Adams, DC1
Grondin, LS1
Tsai, MH1

Other Studies

2 other studies available for succinylcholine and Depressive Disorder, Treatment-Resistant

ArticleYear
Bilateral Forearm Fractures During Modified Electroconvulsive Therapy in a Male Patient With a History of Hyperparathyroidism and Elevated Pseudocholinesterase Activity.
    The journal of ECT, 2019, Volume: 35, Issue:3

    Topics: Aged; Anesthesia; Arm Injuries; Butyrylcholinesterase; Depressive Disorder, Major; Depressive Disord

2019
Electroconvulsive Therapy Considerations for Transgendered Patients.
    The journal of ECT, 2017, Volume: 33, Issue:2

    Topics: Adult; Androstanols; Apnea; Butyrylcholinesterase; Depressive Disorder, Treatment-Resistant; Drug In

2017